DaVita HealthCare Partners Inc (NYSE:DVA) — Market Cap & Net Worth
Market Cap & Net Worth: DaVita HealthCare Partners Inc (DVA)
DaVita HealthCare Partners Inc (NYSE:DVA) has a market capitalization of $11.72 Billion ($11.72 Billion) as of September 23, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1995 globally and #741 in its home market, demonstrating a -2.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DaVita HealthCare Partners Inc's stock price $183.72 by its total outstanding shares 63800000 (63.80 Million). Also see DaVita HealthCare Partners Inc (DVA) total assets for a full breakdown of the balance sheet.
DaVita HealthCare Partners Inc Market Cap History: 2015 to 2026
DaVita HealthCare Partners Inc's market capitalization history from 2015 to 2026. Data shows growth from $4.45 Billion to $11.72 Billion (8.36% CAGR). Also see DaVita HealthCare Partners Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Index Memberships
DaVita HealthCare Partners Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$63.30 Trillion | 0.02% | #439 of 503 |
Weight: DaVita HealthCare Partners Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
DaVita HealthCare Partners Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DaVita HealthCare Partners Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check DaVita HealthCare Partners Inc (DVA) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.53x
DaVita HealthCare Partners Inc's market cap is 0.53 times its annual revenue
Latest Price to Earnings (P/E) Ratio
9.71x
DaVita HealthCare Partners Inc's market cap is 9.71 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $4.10 Billion | $14.75 Billion | $879.87 Million | 0.28x | 4.66x |
| 2017 | $4.61 Billion | $10.88 Billion | $663.62 Million | 0.42x | 6.95x |
| 2018 | $3.28 Billion | $11.40 Billion | $159.39 Million | 0.29x | 20.60x |
| 2019 | $4.79 Billion | $11.39 Billion | $810.98 Million | 0.42x | 5.90x |
| 2020 | $7.49 Billion | $11.55 Billion | $773.64 Million | 0.65x | 9.68x |
| 2021 | $7.26 Billion | $11.62 Billion | $978.45 Million | 0.62x | 7.42x |
| 2022 | $4.76 Billion | $11.61 Billion | $560.40 Million | 0.41x | 8.50x |
| 2023 | $6.68 Billion | $12.14 Billion | $691.53 Million | 0.55x | 9.67x |
| 2024 | $9.54 Billion | $12.82 Billion | $936.34 Million | 0.74x | 10.19x |
| 2025 | $7.25 Billion | $13.64 Billion | $746.80 Million | 0.53x | 9.71x |
Competitor Companies of DVA by Market Capitalization
Companies near DaVita HealthCare Partners Inc in the global market cap rankings as of September 23, 2026. Review DaVita HealthCare Partners Inc tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to DaVita HealthCare Partners Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #293 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #919 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #996 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1242 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #293 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $438.12 |
| #919 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.57 |
| #996 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1242 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $262.06 |
DaVita HealthCare Partners Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, DaVita HealthCare Partners Inc's market cap moved from $4.45 Billion to $ 11.72 Billion, with a yearly change of 8.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $11.72 Billion | +61.71% |
| 2025 | $7.25 Billion | -24.03% |
| 2024 | $9.54 Billion | +42.75% |
| 2023 | $6.68 Billion | +40.30% |
| 2022 | $4.76 Billion | -34.36% |
| 2021 | $7.26 Billion | -3.10% |
| 2020 | $7.49 Billion | +56.47% |
| 2019 | $4.79 Billion | +45.80% |
| 2018 | $3.28 Billion | -28.78% |
| 2017 | $4.61 Billion | +12.54% |
| 2016 | $4.10 Billion | -7.90% |
| 2015 | $4.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of DaVita HealthCare Partners Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.72 Billion USD |
| MoneyControl | $11.72 Billion USD |
| MarketWatch | $11.72 Billion USD |
| marketcap.company | $11.72 Billion USD |
| Reuters | $11.72 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About DaVita HealthCare Partners Inc
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for di… Read more